TherapeuticsMD Inc (OQ:TXMD)

Business Focus: Specialty & Advanced Pharmaceuticals

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for TXMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 29/19 Oct 25/19 Milligan John C.K. IV Direct Ownership Common Stock P - Open market or private purchase 72,000 $2.75
Oct 29/19 Oct 25/19 Milligan John C.K. IV Direct Ownership Common Stock P - Open market or private purchase 72,000 $2.75
Oct 29/19 Oct 25/19 Bernick Brian Direct Ownership Common Stock P - Open market or private purchase 36,000 $2.75
Oct 29/19 Oct 25/19 Finizio Robert G Direct Ownership Common Stock P - Open market or private purchase 72,000 $2.75
Aug 30/19 Aug 28/19 Donegan Michael C Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 120,000  
Aug 30/19 Aug 28/19 Krassan Mitchell Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 300,000  
Aug 30/19 Aug 28/19 Milligan John C.K. IV Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 400,000  
Aug 30/19 Aug 28/19 Bernick Brian Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 300,000  
Aug 30/19 Aug 28/19 Finizio Robert G Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 1  
Aug 30/19 Aug 28/19 Cartwright Daniel A Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 220,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for TXMD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 29/19 Oct 25/19 Milligan John C.K. IV Direct Ownership Common Stock P - Open market or private purchase 72,000 $2.75
Oct 29/19 Oct 25/19 Milligan John C.K. IV Direct Ownership Common Stock P - Open market or private purchase 72,000 $2.75
Oct 29/19 Oct 25/19 Bernick Brian Direct Ownership Common Stock P - Open market or private purchase 36,000 $2.75
Oct 29/19 Oct 25/19 Finizio Robert G Direct Ownership Common Stock P - Open market or private purchase 72,000 $2.75
Aug 30/19 Aug 28/19 Donegan Michael C Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 120,000  
Aug 30/19 Aug 28/19 Krassan Mitchell Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 300,000  
Aug 30/19 Aug 28/19 Milligan John C.K. IV Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 400,000  
Aug 30/19 Aug 28/19 Bernick Brian Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 300,000  
Aug 30/19 Aug 28/19 Finizio Robert G Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 1  
Aug 30/19 Aug 28/19 Cartwright Daniel A Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 220,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $TXMD

Competitors

Competitors with Recent Insider Filings
Jazz Pharmaceuticals PLC (OQ:JAZZ)
Assembly Biosciences (OQ:ASMB)
CorMedix (A:CRMD)